Sales of breast implants linked to cancer to be suspended in Canada
The move against Allergan's Biocell breast implants comes after an ongoing safety review.
Canada's health regulator said Thursday that it is advising Allergan that it intends to suspend the licences for Biocell breast implants as a precautionary measure.
Health Canada said its move followed the completion of its assessment of textured breast implants as part of a larger ongoing safety review of breast implants. -- More...
Read next: CCP Expels 9 Military Leaders Linked to Xi Ahead of Key Meeting
